Literature DB >> 10656172

Altered serum concentrations of TGF-beta 1 and Lp(a) lipoprotein and their correlation in patients with first acute myocardial infarction.

S Djurovic1, D S Thelle, J Ringstad, B Christensen, K Berg.   

Abstract

BACKGROUND AND AIM: The association between high plasma Lp(a) lipoprotein and coronary heart disease has been confirmed in numerous case/control and prospective studies. A high Lp(a) level has also been shown to be an independent genetic risk factor, while its inverse relationship with TGF-beta 1 has suggested that it may interfere with plasmin-mediated activation of TGF-beta 1 and result in increased endothelial activation, as well as migration and proliferation of vascular smooth muscle cells. The aim of this study was to evaluate Lp(a) and TGF-beta 1 and their interactions in patients with first acute myocardial infarction (AMI). METHODS AND
RESULTS: A total of 107 patients with first AMI and 103 age and sex-matched controls were studied. Very good agreement was found between QEI and RIA determinations of Lp(a) (p < 0.0001). Lp(a) levels were significantly elevated in cases (QEI: p < 0.031; RIA p < 0.002 respectively). Division by gender gave statistically significant differences in females only. Plasma levels of the active form of TGF-beta 1 were decreased in cases, though significantly (p < 0.029) in males only.
CONCLUSIONS: Serum concentrations of Lp(a) and TGF-beta 1 are significantly altered in AMI patients. The differences are gender-dependent: Lp(a) is higher in females, and TGF-beta 1 is lower in males. Increased Lp(a) levels are accompanied by decreased active TGF-beta 1 levels and this inverse correlation is statistically significant (p < 0.001).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10656172

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  1 in total

1.  Changes in transforming growth factor β and its receptors' mRNA expression in monocytes from patients with acute coronary syndromes.

Authors:  Andrzej Kulach; Jozefa Dabek; Tadeusz Wilczok; Zbigniew Gasior
Journal:  Arch Med Sci       Date:  2010-09-07       Impact factor: 3.318

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.